Company Overview

Company name: YVY Life Sciences
Description: Producer of cannabis products intended to give people control over their health and improve their life. The company’s products are made from an innovative cultivation model of small, sustainable and standardized farms, with a centralized facility, to produce quality cannabis that is free from chemicals, enabling patients to improve their health and general wellbeing.
Year founded: 2018
Parent company:
Industry: Healthcare | Group: | Code:
Website: www.yvylifesciences.com
Employees:
City: Montevideo
State:
Country: Uruguay
Region:

Financial Highlights

Start up capital raised (USD Million): 1.50
Business status: Startup
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company raised $1.5 million of seed funding in a deal led by Facundo Garreton on March 5, 2020. Other undisclosed investors also participated in the round. The company will use the funds to scale its production of organic cannabidiol products
Number of active investors:
Profile last updated: 10-Mar-2020
Last known valuation:
Last known valuation date: